Cytogenomic Identification and Long-read Single Molecule Real-time (SMRT) Sequencing of a () Deletion
Overview
Authors
Affiliations
Bardet-Biedl syndrome (BBS) is a recessive disorder characterized by heterogeneous clinical manifestations, including truncal obesity, rod-cone dystrophy, renal anomalies, postaxial polydactyly, and variable developmental delays. At least 20 genes have been implicated in BBS, and all are involved in primary cilia function. We report a 1-year-old male child from Guyana with obesity, postaxial polydactyly on his right foot, hypotonia, ophthalmologic abnormalities, and developmental delay, which together indicated a clinical diagnosis of BBS. Clinical chromosomal microarray (CMA) testing and high-throughput BBS gene panel sequencing detected a homozygous 7p14.3 deletion of exons 1-4 of that was encompassed by a 17.5 Mb region of homozygosity at chromosome 7p14.2-p21.1. The precise breakpoints of the deletion were delineated to a 72.8 kb region in the proband and carrier parents by third-generation long-read single molecule real-time (SMRT) sequencing (Pacific Biosciences), which suggested non-homologous end joining as a likely mechanism of formation. Long-read SMRT sequencing of the deletion breakpoints also determined that the aberration included the neighboring gene implicated in retinitis pigmentosa; however, the clinical significance of this was considered uncertain given the paucity of reported cases with unambiguous mutations. Taken together, our study characterized a deletion, and the identification of this shared haplotype in the parents suggests that this pathogenic aberration may be a BBS founder mutation in the Guyanese population. Importantly, this informative case also highlights the utility of long-read SMRT sequencing to map nucleotide breakpoints of clinically relevant structural variants.
Liang W, Zhou Y, Xu Z, Li Y, Chen X, Yu C Pathogens. 2025; 13(12.
PMID: 39770343 PMC: 11728688. DOI: 10.3390/pathogens13121083.
Genomic Analysis of SJ9: An Efficient Tetracycline-, Enrofloxacin-, and Tylosin-Degrading Fungus.
Fu J, Wu X, Zhang C, Tang Y, Zhou F, Zhang X Genes (Basel). 2025; 15(12.
PMID: 39766911 PMC: 11675779. DOI: 10.3390/genes15121643.
Liu Y, Yin C, Zhu M, Zhan Y, Lin M, Yan Y Genes (Basel). 2025; 15(12.
PMID: 39766855 PMC: 11675273. DOI: 10.3390/genes15121588.
Nyaga D, Tsai P, Gebbie C, Phua H, Yap P, Le Quesne Stabej P NPJ Genom Med. 2024; 9(1):57.
PMID: 39516456 PMC: 11549486. DOI: 10.1038/s41525-024-00445-5.
He K, Shi X, Tao Z, Hu X, Sun L, Wang R Microorganisms. 2024; 12(10).
PMID: 39458325 PMC: 11509785. DOI: 10.3390/microorganisms12102016.